These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 33723019)

  • 1. Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis.
    Montes-Andujar L; Tinoco E; Baez-Pravia O; Martin-Saborido C; Blanco-Schweizer P; Segura C; Prol Silva E; Reyes V; Rodriguez Cobo A; Zurdo C; Angel V; Varona O; Valero J; Suarez Del Villar R; Ortiz G; Villanueva J; Menéndez J; Blanco J; Torres A; Cardinal-Fernández PA
    Thorax; 2021 Oct; 76(10):1020-1031. PubMed ID: 33723019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics for community-acquired pneumonia in adult outpatients.
    Pakhale S; Mulpuru S; Verheij TJ; Kochen MM; Rohde GG; Bjerre LM
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD002109. PubMed ID: 25300166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic review.
    El Hajj MS; Turgeon RD; Wilby KJ
    Int J Clin Pharm; 2017 Feb; 39(1):26-32. PubMed ID: 28058593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics for ventilator-associated pneumonia.
    Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.
    R Marques I; P Calvi I; A Cruz S; M F Sanchez L; F Baroni I; Oommen C; H Padrao EM; C Mari P
    Eur J Pediatr; 2022 Nov; 181(11):3795-3804. PubMed ID: 36066660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics for community acquired pneumonia in adult outpatients.
    Bjerre LM; Verheij TJ; Kochen MM
    Cochrane Database Syst Rev; 2004; (2):CD002109. PubMed ID: 15106168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for community-acquired pneumonia in children.
    Kabra SK; Lodha R; Pandey RM
    Cochrane Database Syst Rev; 2010 Mar; (3):CD004874. PubMed ID: 20238334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
    Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
    Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics for community acquired pneumonia in adult outpatients.
    Bjerre LM; Verheij TJ; Kochen MM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD002109. PubMed ID: 19821292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
    Gotfried MH; Dattani D; Riffer E; Devcich KJ; Busman TA; Notario GF; Palmer RN
    Clin Ther; 2002 May; 24(5):736-51. PubMed ID: 12075942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis.
    Eljaaly K; Wali H; Basilim A; Alharbi A; Asfour HZ
    Int J Antimicrob Agents; 2019 Aug; 54(2):149-153. PubMed ID: 31173864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for community-acquired pneumonia in children.
    Lodha R; Kabra SK; Pandey RM
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004874. PubMed ID: 23733365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
    Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shorter versus longer durations of antibiotic treatment for patients with community-acquired pneumonia: a protocol for a systematic review and meta-analysis.
    Agarwal A; Gao Y; Colunga Lozano LE; Asif S; Bakaa L; Ghadimi M; Basmaji J; Das A; Loeb M; Guyatt G
    BMJ Open; 2022 Jun; 12(6):e062428. PubMed ID: 35750458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
    File TM; Eckburg PB; Talbot GH; Llorens L; Friedland HD
    Int J Antimicrob Agents; 2017 Aug; 50(2):247-251. PubMed ID: 28599867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.
    Corrêa JC; Badaró R; Bumroongkit C; Mera JR; Dolmann AL; Juárez Martínez LG; Mayrinck LR; Tamez R; Yang JY
    Clin Ther; 2003 May; 25(5):1453-68. PubMed ID: 12867221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of different antibiotic regimens for the treatment of infective endocarditis.
    Martí-Carvajal AJ; Dayer M; Conterno LO; Gonzalez Garay AG; Martí-Amarista CE
    Cochrane Database Syst Rev; 2020 May; 5(5):CD009880. PubMed ID: 32407558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.